These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3707981)

  • 1. Prenyltransferase and squalene synthetase in livers of neonate rats.
    Bruenger E; Rilling HC
    Biochim Biophys Acta; 1986 May; 876(3):500-6. PubMed ID: 3707981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postnatal developmental profile of 3-hydroxy-3-methylglutaryl-CoA reductase, squalene synthetase and cholesterol 7 alpha-hydroxylase activities in the liver of domestic swine.
    Kwekkeboom J; Kempen HJ; van Voorthuizen EM; Griffioen M; Cohen LH
    Biochim Biophys Acta; 1990 Jan; 1042(1):146-9. PubMed ID: 2297519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mechanism of the condensation reactions of cholesterol biosynthesis. Fourth Morton lecture.
    Rilling HC
    Biochem Soc Trans; 1985 Dec; 13(6):997-1003. PubMed ID: 4092833
    [No Abstract]   [Full Text] [Related]  

  • 4. Squalene synthetase activity in human fibroblasts: regulation via the low density lipoprotein receptor.
    Faust JR; Goldstein JL; Brown MS
    Proc Natl Acad Sci U S A; 1979 Oct; 76(10):5018-22. PubMed ID: 228272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the regulation of glycoprotein biosynthesis. An investigation of the rate-limiting steps of dolichyl phosphate biosynthesis.
    Keller RK; Adair WL; Ness GC
    J Biol Chem; 1979 Oct; 254(20):9966-9. PubMed ID: 489612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of squalene synthetase activity in rat liver: elevation by cholestyramine, but no diurnal variation.
    Cohen LH; Griffioen AM; Wanders RJ; Van Roermund CW; Huysmans CM; Princen HM
    Biochem Biophys Res Commun; 1986 Jul; 138(1):335-41. PubMed ID: 2943275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of squalene synthetase in human hepatoma cell line Hep G2 by sterols, and not by mevalonate-derived non-sterols.
    Cohen LH; van Miert E; Griffioen M
    Biochim Biophys Acta; 1989 Mar; 1002(1):69-73. PubMed ID: 2538145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in the biosynthesis of cholesterol, dolichol and dolichyl-P in the genetic cholesterol homeostasis disorder, Niemann-Pick type C disease.
    Schedin S; Nilsson M; Chojnacki T; Dallner G
    Biochim Biophys Acta; 1998 Nov; 1394(2-3):177-86. PubMed ID: 9795206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isoprenoid biosynthesis in rat liver peroxisomes. Characterization of cis-prenyltransferase and squalene synthetase.
    Ericsson J; Appelkvist EL; Thelin A; Chojnacki T; Dallner G
    J Biol Chem; 1992 Sep; 267(26):18708-14. PubMed ID: 1527001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-dependent changes in rat liver prenyltransferases.
    Thelin A; Runquist M; Ericsson J; Swiezewska E; Dallner G
    Mech Ageing Dev; 1994 Oct; 76(2-3):165-76. PubMed ID: 7885063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of squalene synthase and squalene epoxidase in tobacco cells triggers an up-regulation of 3-hydroxy-3-methylglutaryl coenzyme a reductase.
    Wentzinger LF; Bach TJ; Hartmann MA
    Plant Physiol; 2002 Sep; 130(1):334-46. PubMed ID: 12226513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Activities of 3-hydroxyl-3-methylglutaryl-CoA reductase and acetyl-CoA carboxylase and the rate of mevalonic acid, squalene, sterol and fatty acid biosynthesis from [1-14C]acetyl-CoA and [2-14C]malonyl-CoA in rat liver: effects of Triton WR 1339, starvation and cholesterol diet].
    Poliakova ED; Dizhe EB; Klimova TA; Denisenko TV; Vasil'eva LE
    Biokhimiia; 1981 Feb; 46(2):296-305. PubMed ID: 6113854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzymes of the mevalonate pathway in rat liver nodules induced by 2-acetylaminofluorene treatment.
    Olsson JM; Schedin S; Teclebrhan H; Eriksson LC; Dallner G
    Carcinogenesis; 1995 Mar; 16(3):599-605. PubMed ID: 7697819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivation and activation of various membranal enzymes of the cholesterol biosynthetic pathway by digitonin.
    Eilenberg H; Klinger E; Przedecki F; Shechter I
    J Lipid Res; 1989 Aug; 30(8):1127-35. PubMed ID: 2504860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of cholesterol synthesis by squalene synthase inhibitors does not induce myotoxicity in vitro.
    Flint OP; Masters BA; Gregg RE; Durham SK
    Toxicol Appl Pharmacol; 1997 Jul; 145(1):91-8. PubMed ID: 9221828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Activities of 3-hydroxy-3-methylglutaryl-CoA reductase and acetyl-CoA carboxylase and rate of biosynthesis of mevalonic acid, squalene, sterols and fatty acids from [1-14C]acetyl-CoA and [2-14C]malonyl-CoA in rat liver: changes induced by daily rhythm].
    Poliakova ED; Dizhe EB; Klimova TA; Denisenko TV; Vasil'eva LE
    Biokhimiia; 1981 Jan; 46(1):126-39. PubMed ID: 6113851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compensatory responses to inhibition of hepatic squalene synthase.
    Lopez D; Chambers CM; Keller RK; Ness GC
    Arch Biochem Biophys; 1998 Mar; 351(2):159-66. PubMed ID: 9514656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lead nitrate-induced development of hypercholesterolemia in rats: sterol-independent gene regulation of hepatic enzymes responsible for cholesterol homeostasis.
    Kojima M; Masui T; Nemoto K; Degawa M
    Toxicol Lett; 2004 Dec; 154(1-2):35-44. PubMed ID: 15475176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The regulation of activity of main mevalonic acid pathway enzymes: farnesyl diphosphate synthase, 3-hydroxy-3-methylglutaryl-CoA reductase, and squalene synthase in yeast Saccharomyces cerevisiae.
    Szkopińska A; Swiezewska E; Karst F
    Biochem Biophys Res Commun; 2000 Jan; 267(1):473-7. PubMed ID: 10623644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RPR 107393, a potent squalene synthase inhibitor and orally effective cholesterol-lowering agent: comparison with inhibitors of HMG-CoA reductase.
    Amin D; Rutledge RZ; Needle SN; Galczenski HF; Neuenschwander K; Scotese AC; Maguire MP; Bush RC; Hele DJ; Bilder GE; Perrone MH
    J Pharmacol Exp Ther; 1997 May; 281(2):746-52. PubMed ID: 9152381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.